Joby Aviation (JOBY.US) partners with NVIDIA Corporation (NVDA.US) to develop autonomous flying technology.
Joby Aviation partners with NVIDIA to advance the development of autonomous flight technology.
Joby Aviation (JOBY.US) is collaborating with NVIDIA Corporation (NVDA.US) to advance the development of the company's autonomous flight technology "Superpilot" by integrating NVIDIA Corporation's IGX Thor computing platform. With support from NVIDIA Corporation's Blackwell architecture, IGX Thor aims to power the next generation of physical artificial intelligence applications.
Gregor Veble Miki, Flight Research Director at Joby Aviation, stated: "The autonomous systems being developed by the company can compensate for human limitations and provide speed, accuracy, and endurance beyond the capabilities of an individual. To achieve this goal, an aircraft needs to be equipped with a powerful onboard computer that can process vast amounts of information and make decisions in real-time."
By combining IGX Thor with Joby Aviation's aircraft design and flight test capabilities, NVIDIA Corporation and Joby Aviation can accelerate the development of autonomous aviation technology. With advanced computing capabilities, this aircraft will be able to autonomously determine, request, and follow the best flight path, adapt to weather conditions, air traffic control instructions, or unexpected situations, and even make judgments with human-like intuition.
Furthermore, this platform will allow the aircraft to predict when system components need maintenance and alert crew members before any component failures occur.
Following the announcement, Joby Aviation's stock price rose by over 10% in after-hours trading.
Related Articles

STANCHART (02888) spent approximately 2.1671 million to repurchase around 146,000 shares on October 28th.

CONCH ENVIRO(00587): Anhui CONCH ENVIRO Group's net profit for the first three quarters was 33.16 million yuan.

LIFETECH SCI (01302) announces the two-year follow-up results of the Phase II clinical study and Phase III clinical study of the IBS absorbable drug-eluting coronary stent system.
STANCHART (02888) spent approximately 2.1671 million to repurchase around 146,000 shares on October 28th.

CONCH ENVIRO(00587): Anhui CONCH ENVIRO Group's net profit for the first three quarters was 33.16 million yuan.

LIFETECH SCI (01302) announces the two-year follow-up results of the Phase II clinical study and Phase III clinical study of the IBS absorbable drug-eluting coronary stent system.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


